77 related articles for article (PubMed ID: 9411770)
21. Examining the addictive-like properties of binge eating using an animal model of sugar dependence.
Avena NM
Exp Clin Psychopharmacol; 2007 Oct; 15(5):481-91. PubMed ID: 17924782
[TBL] [Abstract][Full Text] [Related]
22. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
23. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study.
Rahman S; Zhang J; Engleman EA; Corrigall WA
Neuroscience; 2004; 129(2):415-24. PubMed ID: 15501598
[TBL] [Abstract][Full Text] [Related]
24. Dopamine in disturbances of food and drug motivated behavior: a case of homology?
Di Chiara G
Physiol Behav; 2005 Sep; 86(1-2):9-10. PubMed ID: 16129462
[TBL] [Abstract][Full Text] [Related]
25. Dopamine and selective attention.
Matthysse S
Adv Biochem Psychopharmacol; 1977; 16():667-9. PubMed ID: 883565
[No Abstract] [Full Text] [Related]
26. Dopamine and schizophrenia.
Ashby B
Nature; 1990 Dec; 348(6301):493. PubMed ID: 2174127
[No Abstract] [Full Text] [Related]
27. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat.
Schmidt HD; Anderson SM; Pierce RC
Eur J Neurosci; 2006 Jan; 23(1):219-28. PubMed ID: 16420431
[TBL] [Abstract][Full Text] [Related]
29. Dopamine-acetylcholine interactions in the modulation of glutamate release.
Atzori M; Kanold P; Pineda JC; Flores-Hernandez J
Ann N Y Acad Sci; 2003 Nov; 1003():346-8. PubMed ID: 14684457
[No Abstract] [Full Text] [Related]
30. Addiction and the problem of relapse.
Harv Ment Health Lett; 2007 Jan; 23(7):4-7. PubMed ID: 17310529
[No Abstract] [Full Text] [Related]
31. Regulation of gene expression by dopamine: implications in drug addiction.
Conneely OM; Power RF; O'Malley BW
NIDA Res Monogr; 1992; 126():84-97. PubMed ID: 1491719
[No Abstract] [Full Text] [Related]
32. Neurobiology of Adolescent Substance Use Disorders.
Sharma A; Morrow JD
Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):367-75. PubMed ID: 27338961
[TBL] [Abstract][Full Text] [Related]
33. Introduction. The neurobiology of drug addiction: new vistas.
Robbins TW; Everitt BJ; Nutt DJ
Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3109-11. PubMed ID: 18640913
[No Abstract] [Full Text] [Related]
34. A Bayesian Observer Model of Drug Craving.
Gu X; Filbey F
JAMA Psychiatry; 2017 Apr; 74(4):419-420. PubMed ID: 28199454
[No Abstract] [Full Text] [Related]
35. Scientists seek cause of drug craving.
Kuehn BM
JAMA; 2006 Jan; 295(2):148-9. PubMed ID: 16403919
[No Abstract] [Full Text] [Related]
36. Temperature regulation and dopamine in schizophrenia.
Douglass AB; Toogood RW
Biol Psychiatry; 1987 Aug; 22(8):1048-50. PubMed ID: 3038203
[No Abstract] [Full Text] [Related]
37. Cortico-accumbens circuitry in schizophrenia: merely a "reward system"?
Rolland B; Jardri R
Schizophr Res; 2014 Dec; 160(1-3):233-4. PubMed ID: 25458864
[No Abstract] [Full Text] [Related]
38. Dopamine as a mediator of a central stabilizing system.
Friedhoff AJ
Neuropsychopharmacology; 1988 Sep; 1(3):189-91. PubMed ID: 3251500
[No Abstract] [Full Text] [Related]
39. Brain. Editorial.
Compston A
Brain; 2008 Nov; 131(Pt 11):2803-4. PubMed ID: 18984604
[No Abstract] [Full Text] [Related]
40. Drug addiction: bad habits add up.
Robbins TW; Everitt BJ
Nature; 1999 Apr; 398(6728):567-70. PubMed ID: 10217139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]